Miguel Cano - NeuroAiD™

Glossary

February 29, 2024

Understanding Multiple System Atrophy: Differences between MSA-P and MSA-C

Multiple system atrophy (MSA) is a rare and progressive neurodegenerative…

Miguel Cano

Glossary

February 16, 2024

The vital role of the Substantia Nigra: Neurological disorders and beyond

The substantia nigra is an anatomical structure located in the…

Miguel Cano

Glossary

February 16, 2024

Dopamine and strokes: Perspectives and connections

Dopamine is a fundamental neurotransmitter in the functioning of the…

Miguel Cano

Glossary

February 16, 2024

Bradykinesia: Slowness of movement and its neurological significance

Bradykinesia, a medical term that describes slowness in voluntary and…

Miguel Cano

Glossary

February 15, 2024

Understanding Parkinson’s Disease: Symptoms, Causes, and Treatments

Parkinson’s disease is a chronic neurodegenerative disorder that primarily affects…

Miguel Cano

Glossary

February 15, 2024

Progressive Supranuclear Palsy (PSP): A neurodegenerative disease

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder that…

Miguel Cano

Glossary

February 10, 2024

Lumbar puncture in the identification of stroke risk factors

Lumbar puncture is a medical procedure in which a thin…

Miguel Cano

Glossary

February 10, 2024

Electrocardiogram and Stroke: the Influence of Hypertension

The electrocardiogram (ECG) is a tool that records the electrical…

Miguel Cano

Glossary

February 9, 2024

Blood Analysis: key in stroke prevention

Blood analysis can provide important information about stroke risk and…

Miguel Cano

Glossary

February 8, 2024

Nuclear Magnetic Resonance Spectroscopy

Magnetic resonance spectroscopy (MRS), also known as nuclear magnetic resonance…

Miguel Cano